Anika Therapeutics

Bedford, USA
Anika Therapeutics is focused on joint preservation and orthopedic solutions.

About Anika Therapeutics

Anika Therapeutics is a Healthcare company based in Bedford, USA. Anika Therapeutics is focused on joint preservation and orthopedic solutions. It operates on a Direct-to-Consumer (D2C) and Professional Services model. Anika Therapeutics has completed 3 acquisitions, including Arthrosurface, Fidia Farma and Parcus Medical. Anika Therapeutics offers products and services including Integrity Implant System, Tactoset, and Cingal. Its focus areas include Medical Devices and Orthopedic Devices.

Company details

Anika Therapeutics is engaged in developing and delivering early intervention orthopedic solutions. The company specializes in joint preservation and restoration, targeting sectors like osteoarthritis pain management and regenerative medicine. Products such as Integrity Implant System and Tactoset are designed to support tissue regeneration and treat fractures. Solutions are provided for various joints including shoulder, knee, and handwrist. The portfolio also includes non-orthopedic applications in animal health and ophthalmic surgery. Operations are supported by a global network of sales representatives and distributors.

Operational Areas
Key Metrics

Products & Services of Anika Therapeutics

Anika Therapeutics offers a comprehensive portfolio of products and services, including Integrity Implant System, Tactoset, and Cingal.

Integrity Implant System
Regenerative Solutions

A scaffold for tissue regeneration in orthopedic repairs.

Tactoset
Regenerative Solutions

Injectable bone substitute for treating insufficiency fractures.

Cingal
OA Pain Management

Solution for managing osteoarthritis pain in joints.

Apps and channels of Anika Therapeutics

its YouTube channel Anika has 1.97K subscribers and 30 videos.

Anika
YouTube 1.97K subscribers 30 videos Science & Technology
Open channel

Videos from Anika Therapeutics

The most watched videos on Anika Therapeutics's YouTube channel, Anika (1.97K subscribers). Click a video to play it here.

HYALOFAST overview
7K views
Monovisc Product Overview - Information Applies to Outside the US
4.1K views
CINGAL Product Overview - Information Applies to Outside the US
4K views
Integrity Implant Animation
2.9K views

More on Anika.

People of Anika Therapeutics

91 people are tracked at Anika Therapeutics (29 in leadership, 6 in board & advisors, 56 in team).

NameRoleGroup
Mira Leiwant
VP, Regulatory Affairs, Quality, & Clinical AffairsLeadership
Kevin Stone
VP & General Manager, Sports MedicineLeadership
Aislyn Arnone
Marketing DirectorLeadership
Jason Walters
Distributor | General ManagerLeadership
Anne Nunes
VP, OperationsLeadership
Cheryl R. Blanchard
President & CEOLeadership
Ben Joseph
VP, Commercial & Corporate DevelopmentLeadership
Steven Ek
VP, Research & DevelopmentLeadership
Brian Horne
Vice President, Information TechnologyLeadership
George Lakomy
Executive Director Of OperationsLeadership
Jennifer T.
Director, HR Operations & Shared ServicesLeadership
Mustafa Saai
Director Of International Joint Preservation & Restoration - SalesLeadership
Jim Leatham
Business Development Director, Western Europe And CanadaLeadership
Gianluca Ruffi
Director Of International Regenerative SalesLeadership
Sandy Havercroft
Marketing Director - InternationalLeadership
Marley Jones
Vice President FinanceLeadership
Matthew M. Mannarino
Director Of Research & DevelopmentLeadership
Matt Hall
Director, Corporate Development And Investor RelationsLeadership
David B. Colleran
Executive Vice President, General Counsel And Corporate SecretaryLeadership
Weimin Yue Ph.D., Rac
Director Quality AssuranceLeadership

71 more people are available in the full profile.

Premium access

Complete people profiles for Anika Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Anika Therapeutics

Anika Therapeutics has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Arthrosurface, Fidia Farma and Parcus Medical.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Suture anchors and orthopedic instruments are manufactured and distributed.
parcusmedical.comSturgeon Bay, United States2007Jan 2020β€’β€’β€’β€’
3-D printed implants are provided for joint resurfacing and restoration.
arthrosurface.comFranklin, United States2001Jan 2020$60M
Proprietary hyaluronic acid treatments and derivatives are developed.
fidiapharma.comAbano Terme, Italy1946Dec 2009β€’β€’β€’β€’
Premium access

Complete acquisition details for Anika Therapeutics

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Anika Therapeutics

3 dated milestones of Anika Therapeutics across 11 years, from founding to its latest funding, stage changes and deals.

  1. Acquisition Acquires Fidia Farma.
  2. Acquisition Acquires Parcus Medical.
  3. Acquisition Acquires Arthrosurface.

Web traffic of Anika Therapeutics

Websites that share an audience with Anika Therapeutics (anikatherapeutics.com).

Similar websites

Websites whose visitors overlap most with Anika Therapeutics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
flexiontherapeutics.com
75%
View details
theratears.com
62%
10.6K#1,942,966View details

Top companies in Orthopedics

3 companies that operate in the same segment as Anika Therapeutics (Orthopedics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Anika Therapeutics

Anika Therapeutics is engaged in developing and delivering early intervention orthopedic solutions. The company specializes in joint preservation and restoration, targeting sectors like osteoarthritis pain management and regenerative medicine. Products such as Integrity Implant System and Tactoset are designed to support tissue regeneration and treat fractures. Solutions are provided for various joints including shoulder, knee, and handwrist. The portfolio also includes non-orthopedic applications in animal health and ophthalmic surgery. Operations are supported by a global network of sales representatives and distributors.

Anika Therapeutics offers Integrity Implant System, Tactoset, and Cingal.

Anika Therapeutics has made 3 acquisitions, including Arthrosurface, Fidia Farma, and Parcus Medical.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available